Clinical Trial Update: Study of Chemoimmunotherapy for High-Risk Neuroblastoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 trial evaluating chemoimmunotherapy for high-risk neuroblastoma conducted by Memorial Sloan Kettering Cancer Center is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Neuroblastoma (NB) | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING